Pfizer buys Seagen for $43 Billion, boosts access to cancer drugs
Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.
Source: calgaryherald.com
📰 Array Biopharma News
Page 5 - Array Biopharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Array Biopharma. Real-time updates on events, politics, business and more.
Pfizer to boost access to cancer drugs with acquisition
Pfizer is spending about US$43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.
Source: ctvnews.ca
Pfizer buys Seagen for $43B, boosts access to cancer drugs – Metro US
<div class="at-above-post addthis_tool" data-url="https://www.metro.us/pfizer-buys-seagen-for-43b-boosts-access-to-cancer-drugs/"></div>Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue. The pharmaceutical giant said Monday it will pay $229 in cash for each share of Seagen Inc. Pfizer then plans to let the biotech drug developer “continue innovating,” except with mor...
Source: metro.us
Pfizer buys Seagen for $43 billion, seeks new cancer treatments
Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.
Source: pbs.org
Pfizer strikes $43bn deal for cancer drug innovator Seagen
The pharmaceutical giant says it will pay $229 in cash for each share of Seagen.
Albert Bourla Arena Pharmaceuticals Pfizer Chairman Washington Based Seagen Array Biopharma Seattle Genetics
Source: aljazeera.com
Pfizer buys Washington-based Seagen for $43 billion, boosts access to cancer drugs
With its purchase of Washington-based Seagen, Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.
Source: q13fox.com
Pfizer Buys Seagen for $43B, Boosts Access to Cancer Drugs
The pharmaceutical giant said it will pay $229 in cash for each Seagen share.
Albert Bourla Astellas Pharma Inc Arena Pharmaceuticals Pfizer Inc Seagen Inc Washington Based Seagen
Source: manufacturing.net
Pfizer buys Bothell's Seagen for $43B, boosts access to cancer drugs
Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.
Source: mynorthwest.com
Pfizer Buys Seagen for $43B, Boosts Access to Cancer Drugs
The pharmaceutical giant said it will pay $229 in cash for each Seagen share.
Albert Bourla Astellas Pharma Inc Arena Pharmaceuticals Pfizer Inc Seagen Inc Washington Based Seagen
Source: mbtmag.com
Colorectal Cancer Drugs Global Market Report 2023: Sector to Reach $16.22 Billion in 2027 at a CAGR of 3.3%
/PRNewswire/ -- The "Colorectal Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.coms offering. This report provides...
Source: prnewswire.com